Inspire Medical Systems Retained Earnings (Accumulated Deficit) 2017-2024 | INSP
Inspire Medical Systems retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Inspire Medical Systems retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-0.346B, a 1.71% decline year-over-year.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2023 were $-0.345B, a 6.52% increase from 2022.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2022 were $-0.324B, a 16.06% increase from 2021.
- Inspire Medical Systems retained earnings (accumulated deficit) for 2021 were $-0.279B, a 17.71% increase from 2020.
| Inspire Medical Systems Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-345 |
| 2022 | $-324 |
| 2021 | $-279 |
| 2020 | $-237 |
| 2019 | $-180 |
| 2018 | $-147 |
| 2017 | $-125 |
| 2016 | $ |
| Inspire Medical Systems Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-346 |
| 2024-03-31 | $-355 |
| 2023-12-31 | $-345 |
| 2023-09-30 | $-360 |
| 2023-06-30 | $-352 |
| 2023-03-31 | $-340 |
| 2022-12-31 | $-324 |
| 2022-09-30 | $-327 |
| 2022-06-30 | $-311 |
| 2022-03-31 | $-296 |
| 2021-12-31 | $-279 |
| 2021-09-30 | $-277 |
| 2021-06-30 | $-267 |
| 2021-03-31 | $-254 |
| 2020-12-31 | $-237 |
| 2020-09-30 | $-230 |
| 2020-06-30 | $-219 |
| 2020-03-31 | $-196 |
| 2019-12-31 | $-180 |
| 2019-09-30 | $-171 |
| 2019-06-30 | $-163 |
| 2019-03-31 | $-155 |
| 2018-12-31 | $-147 |
| 2018-09-30 | $-142 |
| 2018-06-30 | $-137 |
| 2018-03-31 | $-132 |
| 2017-12-31 | $-125 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.215B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $40.428B | 21.75 |
| Tempus AI (TEM) | United States | $7.918B | 0.00 |
| Axonics (AXNX) | United States | $3.513B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
| 10x Genomics (TXG) | United States | $2.660B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.67 |
| Azenta (AZTA) | United States | $2.413B | 137.03 |
| Privia Health (PRVA) | United States | $2.280B | 158.92 |
| IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 64.82 |
| Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Phreesia (PHR) | United States | $1.389B | 0.00 |
| Standard BioTools (LAB) | United States | $0.753B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
| Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
| Talkspace (TALK) | United States | $0.343B | 0.00 |
| Pulmonx (LUNG) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
| TruBridge (TBRG) | United States | $0.183B | 13.44 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| 111 (YI) | China | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.034B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |